Rakuten Medical
Phase 3Rakuten Medical, Inc. is a global biotechnology company developing precision, cell-targeting investigational therapies on its Alluminox™ technology platform which, in pre-clinical studies have been shown to induce rapid and selective cell killing and tumor necrosis.
Founded
2010
Focus
AntibodiesBiologics
About
Rakuten Medical, Inc. is a global biotechnology company developing precision, cell-targeting investigational therapies on its Alluminox™ technology platform which, in pre-clinical studies have been shown to induce rapid and selective cell killing and tumor necrosis.
Funding History
3Total raised: $350M
Series C$200MGeneral CatalystFeb 15, 2021
Series B$100MSBI InvestmentMar 15, 2019
Series A$50MSBI InvestmentJun 15, 2017
Company Info
TypePrivate
Founded2010
LocationSan Diego, United States
StagePhase 3
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile